Long-term safety of MRI-guided administration of AAV2-GDNF and gadoteridol in the putamen of individuals with Parkinson’s disease
- 1 December 2022
- journal article
- research article
- Published by Elsevier BV in Molecular Therapy
- Vol. 30 (12), 3632-3638
- https://doi.org/10.1016/j.ymthe.2022.08.003
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Interventional MRI-guided Putaminal Delivery of AAV2-GDNF for a Planned Clinical Trial in Parkinson's DiseaseMolecular Therapy, 2011
- Real-time MR Imaging With Gadoteridol Predicts Distribution of Transgenes After Convection-enhanced Delivery of AAV2 VectorsMolecular Therapy, 2010
- Detection of infusate leakage in the brain using real-time imaging of convection-enhanced deliveryJournal of Neurosurgery, 2008
- Image-Guided Convection-Enhanced Delivery Platform in the Treatment of Neurological DiseasesNeurotherapeutics, 2008
- Real-time imaging of convection-enhanced delivery of viruses and virus-sized particlesJournal of Neurosurgery, 2007
- Real-time image-guided direct convective perfusion of intrinsic brainstem lesionsJournal of Neurosurgery, 2007
- Image-guided convection-enhanced delivery of gemcitabine to the brainstemJournal of Neurosurgery, 2007
- Real-time, Image-Guided, Convection-Enhanced Delivery of Interleukin 13 Bound to Pseudomonas ExotoxinClinical Cancer Research, 2006
- Reflux-free cannula for convection-enhanced high-speed delivery of therapeutic agentsJournal of Neurosurgery, 2005
- Successful and safe perfusion of the primate brainstem: in vivo magnetic resonance imaging of macromolecular distribution during infusionJournal of Neurosurgery, 2002